When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mainly used to make the site work as you expect it to. The information does not directly identify you but can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. However, blocking some types of cookies may impact your experience of the site. You can find more information, including a detailed cookie explanation, on our Cookie Policy.
QP-Brain®
AI-based early-stage neurological disease quantification software for quantification of early brain atrophy and lesions. CE, UKCA marked and 510(k) cleared.
The evolution in brain MRI analysis
With an aging population and the escalating burden of neurodegenerative diseases, there’s a growing need for more accurate assessments to detect early changes in the volume of different brain structures, WMH (white matter hyperintensities) load, and location. QP-Brain® is an AI-powered tool that redefines brain MRI analysis by providing quantitative evaluations for enhanced detection and a better understanding of brain atrophy and lesions.
QP-Brain® automates the quantitative analysis of patients’ brain imaging, consolidating data on brain structure volumes and WMH load/location for aiding diagnostics and follow-up. It also streamlines and improves the efficiency of radiological reporting by communicating the quantitative analysis of patients’ brains.
Seamless brain volume quantification and enhanced features
Quantitative analysis
QP-Brain® offers a quantitative analysis of patients’ brain MRI, delivering automatic quantification and display of imaging findings and data, such as the volumes of key intracranial structures and WMH load/location.
Precision in brain volumetry
Outperforms in assessing central nervous system disorders by measuring absolute and relative volumes of grey and white matter, cerebrospinal fluid, and analyzing 132 distinct brain regions (L/R).
Innovative AI technology
Our patented AI ensemble excels in WMH detection and segmentation, effectively filtering out physiological hyperintensities like ependymal enhancements.
Democratizing access with standard protocols
QP-Brain® supports WMH segmentation using a 2D FLAIR input, obviating the need for 3D-T1.
Objective reporting
Confirm visual findings with objective quantitative results. Leverages an extensive normative database.
Dynamic workflow
Outputs are available for viewing in standard hospital PACS environments, appearing as an additional series in a patient folder. No additional workstations or viewing environments are necessary.
GDPR & HIPAA compliant
Installed on a hospital server behind the firewall, QP-Brain® rendering is anonymized, typically through a secure Cloud environment (AWS, Microsoft Azure).
Product Advantages
QP-Brain® delivers objective longitudinal information of visual findings and boasts versatility, requiring only a FLAIR sequence for WMH analysis, optimizing accessibility for community hospitals.
QP-Brain: redefining the standards of radiological analysis.
Related articles
-
![cover_nature]()
Nature Biopharma Dealmakers – Quibim: empowering biopharma to turn images into actionable predictions using artificial intelligence
Read more
-
![231108_world_radiology_day_Blog_small_v2]()
Frontiers in imaging: celebrating radiological advances with Dr. Regina Beets-Tan on International Day of Radiology
Read more
-
![230927_blog_Ai_Ana]()
AI in radiology: benefits and applications
Read more